# clm_BD4CAF70327B

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 818,000,000 United States dollar  
valid_from: 2015-06-30  
valid_to: 2015-09-30  
published: 2015-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_86055E0F3919  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 818,000,000 United States dollar", as of 2015-06-30 (until 2015-09-30). Claim clm_BD4CAF70327B, https://asof.is/claim/clm_BD4CAF70327B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209515000026/0000882095-15-000026-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209515000026/0000882095-15-000026-index.htm (primary, SEC EDGAR 10-Q Q2 FY2015, published 2015-08-05)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 696,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_BD4CAF70327B](/claim/clm_BD4CAF70327B.md) | [clm_C007A487B9D0](/claim/clm_C007A487B9D0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.